ARMATA PHARMACEUTICALS, INC. Class of Warrant or Right, Outstanding
ARMATA PHARMACEUTICALS, INC. (ARMP) had Class of Warrant or Right, Outstanding of 10.66 million shares as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2026-08-12
- 2026-06-30: Class of Warrant or Right, Outstanding 10.66M shares.
- 2026-03-31: Class of Warrant or Right, Outstanding 10.66M shares.
- 2025-12-31: Class of Warrant or Right, Outstanding 10.66M shares.
- 2025-09-30: Class of Warrant or Right, Outstanding 10.66M shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2026-06-30 | 10.66M shares 10-Q · filed 2026-08-12 |
| 2026-03-31 | 10.66M shares 10-Q · filed 2026-05-13 |
| 2025-12-31 | 10.66M shares 10-K · filed 2026-03-25 |
| 2025-09-30 | 10.66M shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 10.66M shares 10-Q · filed 2025-08-12 |
| 2025-03-31 | 10.66M shares 10-Q · filed 2025-05-14 |
| 2024-12-31 | 19.37M shares 10-K · filed 2026-03-25 |
| 2024-09-30 | 19.37M shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 19.37M shares 10-Q · filed 2024-08-13 |
| 2024-03-31 | 19.37M shares 10-Q · filed 2024-05-07 |
| 2023-12-31 | 19.37M shares 10-K · filed 2025-03-21 |
| 2023-09-30 | 20.55M shares 10-Q · filed 2023-11-14 |
| 2023-06-30 | 20.55M shares 10-Q · filed 2023-08-14 |
| 2023-03-31 | 20.55M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 20.55M shares 10-K · filed 2024-03-21 |
| 2022-09-30 | 20.55M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 20.55M shares 10-Q · filed 2022-08-11 |
| 2022-03-31 | 21.15M shares 10-Q · filed 2022-05-12 |
| 2021-12-31 | 16.65M shares 10-K · filed 2022-03-17 |
| 2021-09-30 | 16.65M shares 10-Q · filed 2021-11-10 |
| 2021-06-30 | 16.65M shares 10-Q · filed 2021-08-12 |
| 2021-03-31 | 16.65M shares 10-Q · filed 2021-05-13 |
| 2020-12-31 | 10.55M shares 10-K · filed 2021-03-18 |
| 2020-09-30 | 10.55M shares 10-Q · filed 2020-11-12 |
| 2020-06-30 | 10.55M shares 10-Q · filed 2020-08-13 |
| 2020-03-31 | 10.55M shares 10-Q · filed 2020-05-14 |
| 2019-12-31 | 1.85M shares 10-K · filed 2020-03-19 |
| 2019-09-30 | 1.85M shares 10-Q · filed 2019-11-12 |
| 2019-06-30 | 1.85M shares 10-Q · filed 2019-08-14 |
| 2019-03-31 | 26.48M shares 10-Q · filed 2019-05-06 |
| 2018-12-31 | 26.96M shares 10-K · filed 2019-03-25 |
| 2018-09-30 | 8.29M shares 10-Q · filed 2018-11-08 |
| 2018-06-30 | 8.30M shares 10-Q · filed 2018-08-09 |
| 2018-03-31 | 8.30M shares 10-Q · filed 2018-05-15 |
| 2017-12-31 | 8.53M shares 10-K · filed 2018-03-14 |
| 2017-09-30 | 8.71M shares 10-Q · filed 2017-11-14 |
| 2017-06-30 | 8.98M shares 10-Q · filed 2017-08-14 |
| 2017-03-31 | 775.14K shares 10-Q · filed 2017-05-15 |
| 2016-12-31 | 7.75M shares 10-K · filed 2017-03-27 |
| 2016-09-30 | 2.44M shares 10-Q · filed 2016-11-10 |
| 2016-06-30 | 2.44M shares 10-Q · filed 2016-08-15 |
| 2016-03-31 | 1.38M shares 10-Q · filed 2016-05-12 |
| 2015-12-31 | 1.21M shares 10-K · filed 2017-03-27 |
| 2015-09-30 | 1.21M shares 10-Q · filed 2015-11-16 |
| 2015-06-30 | 1.21M shares 10-Q · filed 2015-08-13 |
| 2015-03-31 | 63.31M shares 10-Q · filed 2015-05-15 |
| 2014-12-31 | 38.89M shares 10-K · filed 2015-04-15 |
| 2014-03-31 | 38.43M shares 10-Q · filed 2014-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| enGene Therapeutics Inc. (ENGN) | $0.129B | -0.92 | |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| LENZ Therapeutics, Inc. (LENZ) | United States | $0.117B | -1.41 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |